聯化科技(002250.SZ):子公司部分生產線恢復生產
格隆匯3月18日丨聯化科技(002250.SZ)公佈,日前公司接響水縣相關部門通知,經市相關部門複核,鹽城市人民政府批覆,江蘇聯化一車間1500t/a廣滅靈(CLZ)項目、二車間500t/a索酚磺酰胺(SFT)項目、九車間600t/a丙酸丁酯(XDE)項目、50t/a嗪草酸甲酯(FM)項目、十車間300t/a甲蟲胺(LT226)項目、十一車間200t/a氟磺胺草醚(CM-1)項目(部分工藝單元)、300t/a唑草酮(CAF)項目、十二車間500t/a聯苯菌胺(FL923)項目、十五車間200t/a3-氨基-2-(1,3二甲基丁基)噻吩(ATA)項目等9條生產線項目和鹽城聯化三車間500t/aJG303項目、四車間5000t/a鄰氯苯腈項目2條生產線項目及相關配套設施在完成設備調試工作的基礎上,可進入正常生產階段。
此次獲得復產批覆的生產線項目2018年度產生的扣除內部交易後的營業收入合計為9.69億元,佔公司2018年度營業收入比例約為23.56%。
截止公吿日,江蘇聯化和鹽城聯化共計20條生產線恢復生產。公司將根據客户訂單需求合理安排生產計劃,敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.